-
Article
Open AccessNeutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice
Clinical practice adherence to current guidelines that recommend primary prophylaxis (PP) with granulocyte colony-stimulating factors (G-CSFs) for patients at high (≥20 %) overall risk of febrile neutropenia (...
-
Article
Open AccessPhase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer
The aim of this phase I/II study was to determine the maximum tolerated dose (MTD) and the dose-limiting toxicities of chronic oral etoposide given on days 1–10 followed by rescue with subcutaneous (s.c.) gran...
-
Chapter
Schwangerschaftsbedingte Trophoblasttumoren
Die Inzidenz der Blasenmole in Europa und in den Vereinigten Staaten wird zwischen 1:1000 bis 1:2000 Geburten angegeben, wobei Chorionkarzinome in einer Häufigkeit von 1:20.000 bis 1:40.000 Schwangerschaften b...
-
Article
Prognostic influence of delays between exploratory and definitive laparotomy in the treatment of malignant ovarian tumors
Background: The aim of this retrospective study was to evaluate whether a delay between a preliminary exploratory laparotomy and a definitive staging laparotomy and interval chemotherapy between the two operat...
-
Article
Open AccessCA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer
The prognostic influence of CA 125 regression between the time point before surgery and after two completed courses of chemotherapy was studied in 210 patients with advanced ovarian cancer, and was compared to...
-
Chapter
Korpuskarzinom
-
Chapter
Zervixkarzinom
-
Article
Abgeschlossene und derzeit laufende adjuvante Therapieprotokolle bei Patientinnen mit operablem Mammakarzinom (II)
Grundlagen: Seit 1984 wurden 4336 Patientinnen mit Mammakarzinom österreichweit in adjuvante Therapiestudien eingebracht.
-
Chapter and Conference Paper
Onkologie und Molekularbiologie im Dialog
Die modernen Technologien der Molekularbiologie haben eine Fülle neuer Erkenntnisse für die Onkologie im allgemeinen und die gynäkologische Onkologie im besonderen erbracht. Die zumeist von Biologen, Biochemik...
-
Article
Onkologie und Molekularbiologie im Dialog
-
Article
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer
Staging and surgical as well as post-operative treatment of primary Fallopian tube carcinoma (FTC) followed the lines established for primary ovarian cancer (OC). In a nationwide retrospective analysis we were...
-
Article
Hormontherapie versus Chemo-Hormontherapie bei Patientinnen mit hormonrezeptorpositivem Mammakarzinom im Stadium I und II
-
Article
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer
Estimation of FGF-3 oncogene amplification in DNA samples extracted from paraffin embedded sections of 136 ovarian cancer samples was carried out by a quantitative PCR method. The aim of this study was to eluc...
-
Article
Serum prostaglandin F2 alpha (PGFM) and oxytocin levels correlate with sonographic changes in the cervix in patients with preterm labor
This is a study on the correlation of maternal serum oxytocin and prostaglandin F2 alpha (PGFM) levels with sonographically measurable changes in the cervix and the internal cervical os in patients with preter...
-
Chapter and Conference Paper
Hormontherapie versus Chemo-Hormontherapie bei Patientinnen mit hormonrezeptorpositivem Mammakarzinom im Stadium I und II
Die Wirksamkeit einer Hormontherapie mit dem Antiöstrogen Tamoxifen bei Hormonrezeptor positivem Mammakarzinom konnte anhand zahlreicher Studien vor allem für die postmenopausale Frau nachgewiesen werden (2). ...
-
Article
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study
A total of 535 chemotherapy naive, hospitalised patients (263 male/272 female) scheduled to receive cisplatin (50-120 mg m-2)-containing regimens participated in a randomised, double-blind, parallel group stud...
-
Article
Der Stellenwert der Second-Look-Operation beim Ovarialkarzinom
Berichtet wird über 171 Patientinnen mit Ovarialkarzinom des Stadiums III und IV, bei welchen nach initialer Operation und Chemotherapie eine Second-Look-Operation durchgeführt wurde. Nach einer medianen follo...
-
Chapter and Conference Paper
Der Stellenwert der Second-Look-Operation beim Ovarialkarzinom
Berichtet wird über 171 Patientinnen mit Ovarialkarzinom des Stadiums III und IV, bei welchen nach initialer Operation und Chemotherapie eine Second-Look-Operation durchgeführt wurde. Nach einer medianen follo...
-
Article
A CA125 score as a prognostic index in patients with ovarian cancer
Due to its high specificity (90%) and sensitivity (86%) measurement of CA125 has become well-established in patients with epithelial ovarian cancer. We have formulated a CA125 prognostic score and examined its...
-
Article
The role of chemotherapy including ifosfamide for ovarian carcinoma
On the basis of the results of earlier studies, 30 departments of gynecology have been cooperating nationwide in Austria since 1980 to promote the use of adjuvant chemotherapy after surgery for cure of ovarian...
